The prevalence and incidence of Toxoplasma antibodies in pregnant women.
DM Franklin, Z Dror, Z Nishri - Israel journal of medical sciences, 1993 - europepmc.org
DM Franklin, Z Dror, Z Nishri
Israel journal of medical sciences, 1993•europepmc.orgA group of 213 pregnant Jewish women of Israeli and North-African/Asian origin in the
Upper Gallilee in Israel were tested for Toxoplasma antibody, first at 4-12 weeks gestation
and again 5-6 months later. Immunofluorescent antibody, Sabin-Feldman tests, and specific
IgM estimation were used. The prevalence rates for seropositive women were lower in both
groups (total 21%) than the rate found in a 1973 study in Israel. The incidence rate for
infection acquired in pregnancy was 1.4%. There were no cases of congenital …
Upper Gallilee in Israel were tested for Toxoplasma antibody, first at 4-12 weeks gestation
and again 5-6 months later. Immunofluorescent antibody, Sabin-Feldman tests, and specific
IgM estimation were used. The prevalence rates for seropositive women were lower in both
groups (total 21%) than the rate found in a 1973 study in Israel. The incidence rate for
infection acquired in pregnancy was 1.4%. There were no cases of congenital …
A group of 213 pregnant Jewish women of Israeli and North-African/Asian origin in the Upper Gallilee in Israel were tested for Toxoplasma antibody, first at 4-12 weeks gestation and again 5-6 months later. Immunofluorescent antibody, Sabin-Feldman tests, and specific IgM estimation were used. The prevalence rates for seropositive women were lower in both groups (total 21%) than the rate found in a 1973 study in Israel. The incidence rate for infection acquired in pregnancy was 1.4%. There were no cases of congenital toxoplasmosis, as far as is known up to 3 years of age. More information on the prevalence and incidence of seropositivity, and on congenital toxoplasmosis, is required before a policy decision can be taken as to whether an antenatal screening program for toxoplasmosis should be instituted in Israel.
europepmc.org